{"pmid":32392461,"title":"The emerging role of lung ultrasound in COVID-19 pneumonia.","text":["The emerging role of lung ultrasound in COVID-19 pneumonia.","In the last decades lung ultrasound (LUS) has become of crucial importance in the evaluation and monitoring of a widely range of pulmonary diseases. One of the major benefits which favours this examination, is that this is a non-invasive, low-cost and radiation-free imaging modality which allows repeated imaging. LUS plays an important role in a wide range of pathologies, including cardiogenic oedema, acute respiratory distress syndrome and fibrosis. Specific LUS findings have proved useful and predictive of acute respiratory distress syndrome which is of particular relevance in the suspicion and monitoring of patients with lung disease. Furthermore, several studies have confirmed the role of LUS in the screening of interstitial lung diseases in connective tissue diseases. Given these data, LUS will likely play an important role in the management of COVID-19 patients from identification of specific abnormalities corresponding to definite pneumonia phases and CT scans findings. In addition, LUS could allow reduction in the exposure of health-care workers to potential infection. Herein, we provide a summary on emerging role of lung ultrasound in COVID-19 pneumonia.","Eur J Rheumatol","Lepri, Gemma","Orlandi, Martina","Lazzeri, Chiara","Bruni, Cosimo","Hughes, Michael","Bonizzoli, Manuela","Wang, Yukai","Peris, Adriano","Matucci-Cerinic, Marco","32392461"],"abstract":["In the last decades lung ultrasound (LUS) has become of crucial importance in the evaluation and monitoring of a widely range of pulmonary diseases. One of the major benefits which favours this examination, is that this is a non-invasive, low-cost and radiation-free imaging modality which allows repeated imaging. LUS plays an important role in a wide range of pathologies, including cardiogenic oedema, acute respiratory distress syndrome and fibrosis. Specific LUS findings have proved useful and predictive of acute respiratory distress syndrome which is of particular relevance in the suspicion and monitoring of patients with lung disease. Furthermore, several studies have confirmed the role of LUS in the screening of interstitial lung diseases in connective tissue diseases. Given these data, LUS will likely play an important role in the management of COVID-19 patients from identification of specific abnormalities corresponding to definite pneumonia phases and CT scans findings. In addition, LUS could allow reduction in the exposure of health-care workers to potential infection. Herein, we provide a summary on emerging role of lung ultrasound in COVID-19 pneumonia."],"journal":"Eur J Rheumatol","authors":["Lepri, Gemma","Orlandi, Martina","Lazzeri, Chiara","Bruni, Cosimo","Hughes, Michael","Bonizzoli, Manuela","Wang, Yukai","Peris, Adriano","Matucci-Cerinic, Marco"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32392461","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.5152/eurjrheum.2020.2063","topics":["Diagnosis"],"weight":1,"_version_":1666528580187717633,"score":9.490897,"similar":[{"pmid":32409232,"pmcid":"PMC7196401","title":"Lung Ultrasound in Children with COVID-19: Preliminary Findings.","text":["Lung Ultrasound in Children with COVID-19: Preliminary Findings.","Recent evidence indicates the usefulness of lung ultrasound (LUS) in detecting coronavirus disease 19 (COVID-19) pneumonia. However, no data are available on the use of LUS in children with COVID-19 pneumonia. In this report, we describe LUS features of 10 consecutively admitted children with COVID-19 in two tertiary-level pediatric hospitals in Rome. LUS revealed signs of lung involvement during COVID-19 infection. In particular, vertical artifacts (70%), pleural irregularities (60%), areas of white lung (10%) and subpleural consolidations (10%) were the main findings in patients with COVID-19. No cases of pleural effusions were found. According to our experience, the routine use of LUS in the evaluation of children with suspected or confirmed COVID-19, when performed by clinicians with documented experience in LUS, was useful in diagnosing and monitoring pediatric COVID-19 pneumonia, reducing unnecessary radiation/sedation in children and exposure of health care workers to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","Ultrasound Med Biol","Musolino, Anna Maria","Supino, Maria Chiara","Buonsenso, Danilo","Ferro, Valentina","Valentini, Piero","Magistrelli, Andrea","Lombardi, Mary Haywood","Romani, Lorenza","D'Argenio, Patrizia","Campana, Andrea","32409232"],"abstract":["Recent evidence indicates the usefulness of lung ultrasound (LUS) in detecting coronavirus disease 19 (COVID-19) pneumonia. However, no data are available on the use of LUS in children with COVID-19 pneumonia. In this report, we describe LUS features of 10 consecutively admitted children with COVID-19 in two tertiary-level pediatric hospitals in Rome. LUS revealed signs of lung involvement during COVID-19 infection. In particular, vertical artifacts (70%), pleural irregularities (60%), areas of white lung (10%) and subpleural consolidations (10%) were the main findings in patients with COVID-19. No cases of pleural effusions were found. According to our experience, the routine use of LUS in the evaluation of children with suspected or confirmed COVID-19, when performed by clinicians with documented experience in LUS, was useful in diagnosing and monitoring pediatric COVID-19 pneumonia, reducing unnecessary radiation/sedation in children and exposure of health care workers to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."],"journal":"Ultrasound Med Biol","authors":["Musolino, Anna Maria","Supino, Maria Chiara","Buonsenso, Danilo","Ferro, Valentina","Valentini, Piero","Magistrelli, Andrea","Lombardi, Mary Haywood","Romani, Lorenza","D'Argenio, Patrizia","Campana, Andrea"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409232","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ultrasmedbio.2020.04.026","keywords":["children","coronavirus disease 19 (covid-19)","lung ultrasound","severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"],"locations":["Rome"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1666989866135584769,"score":513.46643},{"pmid":32416318,"title":"Lung Ultrasound for Cardiologists in the Time of COVID-19.","text":["Lung Ultrasound for Cardiologists in the Time of COVID-19.","Lung ultrasound (LUS) is a point-of-care ultrasound (POCUS) technique used for its portability, widespread availability, and ability to provide real-time diagnostic information procedural guidance. LUS outperforms lung auscultation and chest X-ray, and is an alternative to chest computed tomography in select cases. Cardiologists may enhance their physical and echocardiographic examination with the addition of LUS. We present a practical guide to LUS, including device selection, scanning, findings, and interpretation. We outline a 3-point scanning protocol using 2D and M-mode imaging to evaluate the pleural line, pleural space, and parenchyma. We describe LUS findings and interpretation for common causes of respiratory failure. We provide guidance specific of COVID-19, which at the time of writing is responsible for a global pandemic. In this context, LUS emerges as a particularly useful tool for the diagnosis and management of patients with cardiopulmonary disease.","Can J Cardiol","Kiamanesh, Omid","Harper, Lea","Wiskar, Katie","Luksun, Warren","McDonald, Michael","Ross, Heather","Woo, Anna","Granton, John","32416318"],"abstract":["Lung ultrasound (LUS) is a point-of-care ultrasound (POCUS) technique used for its portability, widespread availability, and ability to provide real-time diagnostic information procedural guidance. LUS outperforms lung auscultation and chest X-ray, and is an alternative to chest computed tomography in select cases. Cardiologists may enhance their physical and echocardiographic examination with the addition of LUS. We present a practical guide to LUS, including device selection, scanning, findings, and interpretation. We outline a 3-point scanning protocol using 2D and M-mode imaging to evaluate the pleural line, pleural space, and parenchyma. We describe LUS findings and interpretation for common causes of respiratory failure. We provide guidance specific of COVID-19, which at the time of writing is responsible for a global pandemic. In this context, LUS emerges as a particularly useful tool for the diagnosis and management of patients with cardiopulmonary disease."],"journal":"Can J Cardiol","authors":["Kiamanesh, Omid","Harper, Lea","Wiskar, Katie","Luksun, Warren","McDonald, Michael","Ross, Heather","Woo, Anna","Granton, John"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416318","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.cjca.2020.05.008","topics":["Diagnosis"],"weight":1,"_version_":1666994545948098563,"score":501.937},{"pmid":32500849,"title":"Frequency of Abnormalities Detected by Point-of-Care Lung Ultrasound in Symptomatic COVID-19 Patients: Systematic Review and Meta-Analysis.","text":["Frequency of Abnormalities Detected by Point-of-Care Lung Ultrasound in Symptomatic COVID-19 Patients: Systematic Review and Meta-Analysis.","The COVID-19 pandemic has resulted in significant morbidity, mortality, and strained healthcare systems worldwide. Thus, a search for modalities that can expedite and improve the diagnosis and management of this entity is underway. Recent data suggested the utility of lung ultrasound (LUS) in the diagnosis of COVID-19 by detecting an interstitial pattern (B-pattern). Hence, we aimed to pool the proportion of various reported lung abnormalities detected by LUS in symptomatic COVID-19 patients. We conducted a systematic review (PubMed, MEDLINE, and EMBASE until April 25, 2020) and a proportion meta-analysis. We included seven studies examining the role of LUS in 122 COVID-19 patients. The pooled proportion (PP) of B-pattern detected by lung ultrasound (US) was 0.97 (95% CI: 0.94-1.00 I (2) 0%, Q 4.6). The PP of finding pleural line abnormalities was 0.70 (95% CI: 0.13-1.00 I (2) 96%, Q 103.9), of pleural thickening was 0.54 (95% 0.11-0.95 I (2) 93%, Q 61.1), of subpleural or pulmonary consolidation was 0.39 (95% CI: 0.21-0.58 I (2) 72%, Q 17.8), and of pleural effusion was 0.14 (95% CI: 0.00-0.37 I (2) 93%, Q 27.3). Our meta-analysis revealed that almost all SARS-CoV-2-infected patients have abnormal lung US. The most common abnormality is interstitial involvement depicted as B-pattern. The finding from our review highlights the potential role of this modality in the triage, diagnosis, and follow-up of COVID-19 patients. A sizable diagnostic accuracy study comparing LUS, computed tomography scan, and COVID-19-specific tests is warranted to further test this finding and to delineate the diagnostic and prognostic yield of each of these modalities.","Am J Trop Med Hyg","Mohamed, Mouhand F H","Al-Shokri, Shaikha","Yousaf, Zohaib","Danjuma, Mohammed","Parambil, Jessiya","Mohamed, Samreen","Mubasher, Mahmood","Dauleh, Mujahed M","Hasanain, Bara","AlKahlout, Mohamed Awni","Abubeker, Ibrahim Y","32500849"],"abstract":["The COVID-19 pandemic has resulted in significant morbidity, mortality, and strained healthcare systems worldwide. Thus, a search for modalities that can expedite and improve the diagnosis and management of this entity is underway. Recent data suggested the utility of lung ultrasound (LUS) in the diagnosis of COVID-19 by detecting an interstitial pattern (B-pattern). Hence, we aimed to pool the proportion of various reported lung abnormalities detected by LUS in symptomatic COVID-19 patients. We conducted a systematic review (PubMed, MEDLINE, and EMBASE until April 25, 2020) and a proportion meta-analysis. We included seven studies examining the role of LUS in 122 COVID-19 patients. The pooled proportion (PP) of B-pattern detected by lung ultrasound (US) was 0.97 (95% CI: 0.94-1.00 I (2) 0%, Q 4.6). The PP of finding pleural line abnormalities was 0.70 (95% CI: 0.13-1.00 I (2) 96%, Q 103.9), of pleural thickening was 0.54 (95% 0.11-0.95 I (2) 93%, Q 61.1), of subpleural or pulmonary consolidation was 0.39 (95% CI: 0.21-0.58 I (2) 72%, Q 17.8), and of pleural effusion was 0.14 (95% CI: 0.00-0.37 I (2) 93%, Q 27.3). Our meta-analysis revealed that almost all SARS-CoV-2-infected patients have abnormal lung US. The most common abnormality is interstitial involvement depicted as B-pattern. The finding from our review highlights the potential role of this modality in the triage, diagnosis, and follow-up of COVID-19 patients. A sizable diagnostic accuracy study comparing LUS, computed tomography scan, and COVID-19-specific tests is warranted to further test this finding and to delineate the diagnostic and prognostic yield of each of these modalities."],"journal":"Am J Trop Med Hyg","authors":["Mohamed, Mouhand F H","Al-Shokri, Shaikha","Yousaf, Zohaib","Danjuma, Mohammed","Parambil, Jessiya","Mohamed, Samreen","Mubasher, Mahmood","Dauleh, Mujahed M","Hasanain, Bara","AlKahlout, Mohamed Awni","Abubeker, Ibrahim Y"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500849","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.4269/ajtmh.20-0371","locations":["US","US","Symptomatic"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis"],"weight":1,"_version_":1668804508693561345,"score":472.61823},{"pmid":32398268,"title":"Lung ultrasound in the monitoring of COVID-19 infection.","text":["Lung ultrasound in the monitoring of COVID-19 infection.","INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a highly contagious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Pneumonia and acute respiratory distress syndrome (ARDS) are the most common severe complications. There is growing evidence regarding the imaging findings of COVID-19 in chest X-rays and computed tomography (CT) scans; however, their availability to clinical staff in this pandemic outbreak might be compromised. At this moment, the role of lung ultrasound (LUS) has yet to be explored. The purpose of this case report is to describe the natural course of the disease in mild infection managed at home. CASE REPORT: We report a 35-year-old man with recently diagnosed COVID-19 infection. Clinical examination was unremarkable. The diagnosis of mild disease was made clinically which was later reaffirmed by LUS after identifying a bilateral small pleural effusion and a thickened pleural line. During follow up, subpleural consolidations appeared before symptoms slightly aggravated (cough, tiredness and fever). The patient's condition improved after adjustment of therapy at home. CONCLUSION: LUS is an excellent tool in the characterisation of COVID-19 infection and is more available than CT or X-ray. We emphasise the utility and the opportunity that LUS presents in some clinical scenarios, like this COVID-19 pandemic, and how it may serve as a monitoring and therapy guide.","Clin Med (Lond)","Tung-Chen, Yale","32398268"],"abstract":["INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a highly contagious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Pneumonia and acute respiratory distress syndrome (ARDS) are the most common severe complications. There is growing evidence regarding the imaging findings of COVID-19 in chest X-rays and computed tomography (CT) scans; however, their availability to clinical staff in this pandemic outbreak might be compromised. At this moment, the role of lung ultrasound (LUS) has yet to be explored. The purpose of this case report is to describe the natural course of the disease in mild infection managed at home. CASE REPORT: We report a 35-year-old man with recently diagnosed COVID-19 infection. Clinical examination was unremarkable. The diagnosis of mild disease was made clinically which was later reaffirmed by LUS after identifying a bilateral small pleural effusion and a thickened pleural line. During follow up, subpleural consolidations appeared before symptoms slightly aggravated (cough, tiredness and fever). The patient's condition improved after adjustment of therapy at home. CONCLUSION: LUS is an excellent tool in the characterisation of COVID-19 infection and is more available than CT or X-ray. We emphasise the utility and the opportunity that LUS presents in some clinical scenarios, like this COVID-19 pandemic, and how it may serve as a monitoring and therapy guide."],"journal":"Clin Med (Lond)","authors":["Tung-Chen, Yale"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32398268","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.7861/clinmed.2020-0123","keywords":["covid-19","sars-cov-2","lung ultrasound"],"topics":["Case Report"],"weight":1,"_version_":1666865855056576512,"score":468.65775},{"pmid":32478445,"title":"Lung Ultrasound Can Influence the Clinical Treatment of Pregnant Women With COVID-19.","text":["Lung Ultrasound Can Influence the Clinical Treatment of Pregnant Women With COVID-19.","Lung ultrasound (LUS) is an effective tool to detect and monitor patients infected with 2019 coronavirus disease (COVID-19). The use of LUS on pregnant women is an emerging trend, considering its effectiveness during the outbreak. Eight pregnant women with a diagnosis of COVID-19 confirmed by nasal/throat real-time reverse transcription polymerase chain reaction testing who underwent point-of-care LUS examinations after routine obstetric ultrasound are described. A routinely performed LUS examination revealed serious lung involvement in 7 cases: 2 were initially asymptomatic; 3 have chest computed tomography; 1 had initial negative real-time reverse transcription polymerase chain reaction results; and 1 had initial negative computed tomographic findings. Treatment for COVID-19 was either commenced or changed in 87.5% of the patients (n = 7 of 8) on LUS findings. Among patients with abnormal LUS findings, treatment was commenced in 5 patients (71.5%) and changed in 2 patients (28.5%). One normal and 7 abnormal LUS cases indicate the impact of routine LUS on the clinical outcome and treatment of pregnant women.","J Ultrasound Med","Yassa, Murat","Birol, Pinar","Mutlu, Ali Memis","Tekin, Arzu Bilge","Sandal, Kemal","Tug, Niyazi","32478445"],"abstract":["Lung ultrasound (LUS) is an effective tool to detect and monitor patients infected with 2019 coronavirus disease (COVID-19). The use of LUS on pregnant women is an emerging trend, considering its effectiveness during the outbreak. Eight pregnant women with a diagnosis of COVID-19 confirmed by nasal/throat real-time reverse transcription polymerase chain reaction testing who underwent point-of-care LUS examinations after routine obstetric ultrasound are described. A routinely performed LUS examination revealed serious lung involvement in 7 cases: 2 were initially asymptomatic; 3 have chest computed tomography; 1 had initial negative real-time reverse transcription polymerase chain reaction results; and 1 had initial negative computed tomographic findings. Treatment for COVID-19 was either commenced or changed in 87.5% of the patients (n = 7 of 8) on LUS findings. Among patients with abnormal LUS findings, treatment was commenced in 5 patients (71.5%) and changed in 2 patients (28.5%). One normal and 7 abnormal LUS cases indicate the impact of routine LUS on the clinical outcome and treatment of pregnant women."],"journal":"J Ultrasound Med","authors":["Yassa, Murat","Birol, Pinar","Mutlu, Ali Memis","Tekin, Arzu Bilge","Sandal, Kemal","Tug, Niyazi"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478445","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jum.15367","keywords":["covid-19","lung ultrasound","pneumonia","pregnancy","severe acute respiratory syndrome novel coronavirus 2"],"topics":["Case Report"],"weight":1,"_version_":1668437835002150913,"score":466.0483}]}